Open access · US-GOV via ClinicalTrials.gov Clinical trial

Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

Authors not listed

Washington University School of Medicine · 2023

Cellular senescence Senolytics Human Randomized controlled trial

Abstract

This pilot open-label study examines the effects of a combination of dasatinib plus quercetin - two drugs that have known senolytics properties - on physiological aging in older individuals with depression or schizophrenia.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-21 MST

Cite this

APA

Anonymous. (2023). Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders. <em>Washington University School of Medicine</em>. https://clinicaltrials.gov/study/NCT05838560

Vancouver

Anonymous. Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders. Washington University School of Medicine. 2023.

BibTeX

@misc{anon2023Dasati, title = {Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders}, author = {Anonymous}, journal = {Washington University School of Medicine}, year = {2023}, }